Lowering cholesterol with ezetimibe
Treatments studied
Part of Heart & circulation clinical trials.
This trial looks at how well ezetimibe, a medicine that lowers cholesterol, works when taken alone or alongside other cholesterol medicines. It may help people who need extra help lowering their LDL (bad) cholesterol.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You are starting ezetimibe for the first time.
- If you already take a statin or other cholesterol-lowering medicine, you have not changed the type or dose of that medicine when you start ezetimibe.
- If you are starting both ezetimibe and a statin together for the first time, you cannot take part.
- Your doctor says it is appropriate for you to take ezetimibe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two very low LDL-cholesterol targets (below 1.0 vs 1.0-1.39 mmol/L) using extra medications (PCSK9 inhibitors) to see which is safer and better for people at extremely high risk of heart attacks or strokes.
This trial tests whether ezetimibe, a cholesterol-lowering drug, changes the bacteria in your gut. It may help people with heart disease or high cholesterol who are already on a statin.
This study tests whether a combination of two cholesterol-lowering medicines—a low-dose statin and ezetimibe—is safe and feasible for people with very early signs of artery hardening but no major blockages. It aims to see if this treatment can help prevent heart problems from getting worse.
This trial tests whether taking a moderate-strength statin (cholesterol-lowering drug) plus ezetimibe (another cholesterol medicine) together helps protect the heart and kidneys in people who have both chronic kidney disease and established heart disease or stroke history.
This trial studies whether high-intensity statin plus ezetimibe can improve heart health in people who do not have symptoms but have calcium buildup in their heart arteries. It may help lower cholesterol and reduce future heart risks for the right participants.
This trial tests a medicine called Ezefeno to see if it helps lower cholesterol in people with type 2 diabetes who are already on statins. It may be an option if you have high triglycerides and other heart risk factors.
Hear when a new Atherosclerotic Cardiovascular Disease (ASCVD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.